Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Completed				15 and under				Other				2006-02-069 NCT00336531

Last Modified: 7/11/2007 First Published: 6/1/1999


2.		Phase III Randomized Study of Itraconazole Versus Fluconazole to Prevent Asgergillus Infections in Patients Undergoing Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation (Summary Last Modified 10/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				13 and over				NCI				FHCRC-1322.00 NCI-H99-0030, NCT00003883


3.		Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)(COMPLETED)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				13 and over				Pharmaceutical / Industry				P01899 NCT00044486

Last Modified: 1/16/2008 First Published: 9/1/2002


4.		Phase I/II Study of PKC412 With or Without Itraconazole in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				MSKCC-02021 NOVARTIS-CPKC412A2104, NCI-G02-2107, UCLA-0305058-01, NCT00045578

Last Modified: 9/1/1992


5.		An Open, Multicenter, Comparative Study of the Efficacy, Safety, and Tolerance of Fluconazole vs Itraconazole in the Treatment of Cancer Patients with Oropharyngeal Candidiasis (Summary Last Modified 09/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				16 and over								EORTC-19911

Last Modified: 7/12/2007 First Published: 2/20/2004


6.		Randomized Study of Voriconazole Versus Itraconazole for the Prevention of Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				12 and over				NCI				UCLA-0307071 NCT00079222

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute